183 related articles for article (PubMed ID: 27318684)
21. High reproducibility of tumor hypoxia evaluated by 18F-fluoromisonidazole PET for head and neck cancer.
Okamoto S; Shiga T; Yasuda K; Ito YM; Magota K; Kasai K; Kuge Y; Shirato H; Tamaki N
J Nucl Med; 2013 Feb; 54(2):201-7. PubMed ID: 23321456
[TBL] [Abstract][Full Text] [Related]
22. Identifying hypoxia in human tumors: A correlation study between 18F-FMISO PET and the Eppendorf oxygen-sensitive electrode.
Mortensen LS; Buus S; Nordsmark M; Bentzen L; Munk OL; Keiding S; Overgaard J
Acta Oncol; 2010 Oct; 49(7):934-40. PubMed ID: 20831480
[TBL] [Abstract][Full Text] [Related]
23. Gene and protein expression of glucose transporter 1 and glucose transporter 3 in human laryngeal cancer-the relationship with regulatory hypoxia-inducible factor-1α expression, tumor invasiveness, and patient prognosis.
Starska K; Forma E; Jóźwiak P; Bryś M; Lewy-Trenda I; Brzezińska-Błaszczyk E; Krześlak A
Tumour Biol; 2015 Apr; 36(4):2309-21. PubMed ID: 25412955
[TBL] [Abstract][Full Text] [Related]
24. Prognostic role of tumor necrosis, microvessel density, vascular endothelial growth factor and hypoxia inducible factor-1alpha in patients with clear cell renal carcinoma after radical nephrectomy in a long term follow-up.
Minardi D; Lucarini G; Filosa A; Milanese G; Zizzi A; Di Primio R; Montironi R; Muzzonigro G
Int J Immunopathol Pharmacol; 2008; 21(2):447-55. PubMed ID: 18547492
[TBL] [Abstract][Full Text] [Related]
25. Dysregulation of hypoxia inducible factor-1alpha in head and neck squamous cell carcinoma cell lines correlates with invasive potential.
Cohen NA; Lai SY; Ziober AF; Ziober BL
Laryngoscope; 2004 Mar; 114(3):418-23. PubMed ID: 15091212
[TBL] [Abstract][Full Text] [Related]
26. Is the hypoxia-inducible factor pathway important in gastric cancer?
Griffiths EA; Pritchard SA; Welch IM; Price PM; West CM
Eur J Cancer; 2005 Dec; 41(18):2792-805. PubMed ID: 16290133
[TBL] [Abstract][Full Text] [Related]
27. Using DNA, radiation therapy gets personal.
Dolgin E
Science; 2016 Sep; 353(6306):1348-1349. PubMed ID: 27708015
[No Abstract] [Full Text] [Related]
28. Prognostic impact of HIF-1alpha expression in patients with definitive radiotherapy for cervical cancer.
Dellas K; Bache M; Pigorsch SU; Taubert H; Kappler M; Holzapfel D; Zorn E; Holzhausen HJ; Haensgen G
Strahlenther Onkol; 2008 Mar; 184(3):169-74. PubMed ID: 18330514
[TBL] [Abstract][Full Text] [Related]
29. How Advances in Imaging Will Affect Precision Radiation Oncology.
Jaffray DA; Das S; Jacobs PM; Jeraj R; Lambin P
Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):292-298. PubMed ID: 29726358
[TBL] [Abstract][Full Text] [Related]
30. Integrating Mathematical Modeling into the Roadmap for Personalized Adaptive Radiation Therapy.
Enderling H; Alfonso JCL; Moros E; Caudell JJ; Harrison LB
Trends Cancer; 2019 Aug; 5(8):467-474. PubMed ID: 31421904
[TBL] [Abstract][Full Text] [Related]
31. Correlation of hypoxia inducible transcription factor in breast cancer and SUVmax of F-18 FDG PET/CT.
Jeong YJ; Jung JW; Cho YY; Park SH; Oh HK; Kang S
Nucl Med Rev Cent East Eur; 2017; 20(1):32-38. PubMed ID: 28198519
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of hypoxia-inducible factor 1alpha indicates diminished response to radiotherapy and unfavorable prognosis in patients receiving radical radiotherapy for cervical cancer.
Bachtiary B; Schindl M; Pötter R; Dreier B; Knocke TH; Hainfellner JA; Horvat R; Birner P
Clin Cancer Res; 2003 Jun; 9(6):2234-40. PubMed ID: 12796391
[TBL] [Abstract][Full Text] [Related]
33. Expression of Hypoxia-Inducible Factor 1α in Invasive Breast Cancer with Metastasis to Lymph Nodes: Correlation with Steroid Receptors, HER2 and EPO-R.
Badowska-Kozakiewicz A; Sobol M; Patera J
Adv Clin Exp Med; 2016; 25(4):741-50. PubMed ID: 27629849
[TBL] [Abstract][Full Text] [Related]
34. Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial.
Koukourakis MI; Bentzen SM; Giatromanolaki A; Wilson GD; Daley FM; Saunders MI; Dische S; Sivridis E; Harris AL
J Clin Oncol; 2006 Feb; 24(5):727-35. PubMed ID: 16418497
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of [125I]IPOS as a molecular imaging probe for hypoxia-inducible factor-1-active regions in a tumor: comparison among single-photon emission computed tomography/X-ray computed tomography imaging, autoradiography, and immunohistochemistry.
Ueda M; Kudo T; Mutou Y; Umeda IO; Miyano A; Ogawa K; Ono M; Fujii H; Kizaka-Kondoh S; Hiraoka M; Saji H
Cancer Sci; 2011 Nov; 102(11):2090-6. PubMed ID: 21824221
[TBL] [Abstract][Full Text] [Related]
36. Radiation oncology in the era of precision medicine.
Baumann M; Krause M; Overgaard J; Debus J; Bentzen SM; Daartz J; Richter C; Zips D; Bortfeld T
Nat Rev Cancer; 2016 Apr; 16(4):234-49. PubMed ID: 27009394
[TBL] [Abstract][Full Text] [Related]
37. Combining clinicopathological predictors and molecular biomarkers in the oncogenic K-RAS/Ki67/HIF-1α pathway to predict survival in resectable pancreatic cancer.
Qin R; Smyrk TC; Reed NR; Schmidt RL; Schnelldorfer T; Chari ST; Petersen GM; Tang AH
Br J Cancer; 2015 Feb; 112(3):514-22. PubMed ID: 25584484
[TBL] [Abstract][Full Text] [Related]
38. Role of FDG-PET as a biological marker for predicting the hypoxic status of tongue cancer.
Han MW; Lee HJ; Cho KJ; Kim JS; Roh JL; Choi SH; Nam SY; Kim SY
Head Neck; 2012 Oct; 34(10):1395-402. PubMed ID: 22052623
[TBL] [Abstract][Full Text] [Related]
39. Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy.
Tatum JL; Kelloff GJ; Gillies RJ; Arbeit JM; Brown JM; Chao KS; Chapman JD; Eckelman WC; Fyles AW; Giaccia AJ; Hill RP; Koch CJ; Krishna MC; Krohn KA; Lewis JS; Mason RP; Melillo G; Padhani AR; Powis G; Rajendran JG; Reba R; Robinson SP; Semenza GL; Swartz HM; Vaupel P; Yang D; Croft B; Hoffman J; Liu G; Stone H; Sullivan D
Int J Radiat Biol; 2006 Oct; 82(10):699-757. PubMed ID: 17118889
[TBL] [Abstract][Full Text] [Related]
40. Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma.
Bos R; van der Groep P; Greijer AE; Shvarts A; Meijer S; Pinedo HM; Semenza GL; van Diest PJ; van der Wall E
Cancer; 2003 Mar; 97(6):1573-81. PubMed ID: 12627523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]